Airship AI Reports First Quarter 2024 Financial Results
May 15, 2024 08:31 ET
|
Airship AI
Airship AI Reports First Quarter 2024 Financial Results
The Real Good Food Company to Participate in the 24th Annual B. Riley Institutional Investor Conference
May 15, 2024 08:31 ET
|
The Real Good Food Company, Inc.
CHERRY HILL, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated foods...
Yield10 Bioscience Announces Delisting from Nasdaq
May 15, 2024 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a...
BOSS Money Customers Sent Cash Home to Mom at a Record Rate
May 15, 2024 08:30 ET
|
IDT Corporation
Remittances Around Mother’s Day Increased by 46%* Over Last Year Newark, NJ, May 15, 2024 (GLOBE NEWSWIRE) -- BOSS Money, the international money remittance service of IDT Corporation (NYSE: IDT),...
Reliance Global Group Announces Game-Changing Acquisition of Spetner Associates; Projected to Double Company’s Revenue
May 15, 2024 08:30 ET
|
Reliance Global Group, Inc.
Integration expected to drive significant EBITDA growth and shareholder value in 2024 Spetner’s BenManage Benefits enrollment company serving over 75,000 Employees Reliance focused on...
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
May 15, 2024 08:30 ET
|
PaxMedica, Inc.
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for...
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024 08:30 ET
|
Adial Pharmaceuticals, Inc
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies...
Genasys Receives $2.7 Million U.S. Navy Order for LRAD Maritime Systems
May 15, 2024 08:30 ET
|
Genasys Inc.
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, today announced a $2.7 million LRAD systems order from the U.S. Navy (Navy)....
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
May 15, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the last patient in the Company’s Karisma-Endoxifen clinical trial...
Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™
May 15, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 15, 2024 (GLOBE NEWSWIRE) -- Oligonucleotide Synthesis market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at...
- May 15, 2024 08:01 ET Glassdoor Names USI Insurance Services Among the ‘Best-Led Companies’ in the US
- May 15, 2024 08:00 ET The Doggone Foundation donates $150K to the MUHC Foundation to support breast cancer research